companydata.dkLIPLASOME PHARMA ApS: Financial statements 2017
CVR: 29428514
LIPLASOME PHARMA ApS (CVR 29428514) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -65,000 and a net result of DKK -55,000 compared with DKK -309,000 the year before. Equity amounted to DKK 33,838,000. The solvency ratio was 88%.
- Gross Profit
- -65,000 kr.
- Profit/Loss
- -55,000 kr.
- Equity
- 33,838,000 kr.
- Total Assets
- 38,473,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -65 t. | -55 t. | 33.8 mio. | 0 |
| 2016 | - | -328 t. | -309 t. | 33.9 mio. | 0 |
| 2015 | - | -1.7 mio. | -2.5 mio. | 34.2 mio. | 2 |
| 2014 | - | -1.5 mio. | -2.4 mio. | 31.8 mio. | 2 |
| 2013 | - | -1.2 mio. | -147 t. | 34.2 mio. | 2 |
Find more companies like LIPLASOME PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
LIPLASOME PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -328,000, and the net result was DKK -309,000.
About LIPLASOME PHARMA ApS
LIPLASOME PHARMA ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Horsted Eriksen. The company is owned by BAGGER-SØRENSEN & CO. A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -28,000 and a net result of DKK 62,000 compared with DKK -36,000 the year before. Equity amounted to DKK 2,377,000.